States prep for loss of ACA

Several states are working on their own healthcare plans to preserve some coverage and provisions of the Affordable Care Act as the healthcare law makes its way through an appeals court and faces the real possibility of being overturned, The Wall Street Journal reported.

In the absence of a Trump administration healthcare plan to replace the ACA, a huge gap in insurance could be in the future. The ACA is facing its biggest legal challenge to date after a Republican-led lawsuit sought to overturn it and a federal judge declared the entire law unconstitutional last year. While Democrats have appealed the decision, the ACA remains the law of the land.

Some lawmakers in a handful of states, including Louisiana, Nevada, New Mexico and California, have approved legislation or are reviewing action to deal with the possibility that the ACA could be tossed out soon, the WSJ reported. The plans include providing subsidies to high-cost patients, coverage gap solutions and rules to prevent people from being denied coverage.

Part of the motivation by these lawmakers to provide assurance that their constituents would be able to find health insurance in the case that the ACA were to be tossed are tight re-election campaigns, according to the WSJ.

Under the ACA provisions, people with pre-existing conditions cannot be denied health insurance coverage or be forced to pay more for their plan. Those protections would go away if the ACA is invalidated, exposing up to 54 million Americans with a pre-existing condition, according to one estimate.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.